Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
Our Patient Services Director, Julie White, RN, BSN, OCN, sits down with Michael Offin, MD to discuss a clinical trial . Dr. Offin is a
In July 2020, the Mesothelioma UK Research Centre was established at the University of Sheffield, thanks to funding from the national charity, Mesothelioma UK. The
On this episode of MesoTV, our Patient Services Director, Julie White, sits down with Melissa Culligan, PhD, RN. Melissa is the Director of Thoracic Surgery
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
